- ICH GCP
- Amerikanska kliniska prövningsregistret
- Klinisk prövning NCT04522765
Dagliga blodtrycksmönster hos personer med ökad risk för hjärt-kärlsjukdom
Mönster för dygnsblodtryck och arteriell stelhet hos personer med ökad risk för kardiovaskulära sjukdomar
In health, blood pressure (BP) falls at night by >10% compared with day-time values. This natural dipping pattern is important as without it there is an increased risk of cardiovascular disease (CVD). Recent evidence suggests that chronotherapy (taking anti-hypertensive medication at bedtime instead of in the morning) may enhance nocturnal BP dipping and reduce the risk of CVD events. There is therefore an urgent need to characterise diurnal BP patterns in patients who may be at risk of reduced nocturnal dipping in order to maximise protective therapy in all those who would benefit. Similarly, it has previously been demonstrated that increased arterial stiffness is associated with increased CVD risk, however little is known about whether loss of diurnal variations in arterial stiffness confer addition risk. Kidney disease is independently associated with increased CVD events, but the exact makeup of this risk is not clear. Within this heterogenous cohort several very distinct groups exist including those with acute kidney injury (AKI), chronic kidney disease (CKD), inflammatory conditions like small vessel vasculitis (SVV), and those who have either donated or received a kidney transplant. Diurnal BP and arterial stiffness patterns within these patient groups are not well characterised. The investigators will recruit patients at increased risk of CVD from the Royal Infirmary of Edinburgh Renal and Vasculitis Clinics. Participants will undergo 24-hour ambulatory BP and arterial stiffness measurement in conjunction with day- and night-time blood and urine sampling on two separate occasions. This study aims to characterise diurnal patterns of BP and arterial stiffness in patients at increased risk of CVD and compare findings with healthy controls. In doing so, the investigators aim to allow more targeted CVD risk reduction strategies and improve long-term patient outcomes.
Studieöversikt
Status
Intervention / Behandling
Studietyp
Inskrivning (Beräknad)
Kontakter och platser
Studiekontakt
- Namn: Neeraj Dhaun, MBChB PhD
- Telefonnummer: 07968810899
- E-post: bean.dhaun@ed.ac.uk
Studieorter
-
-
-
Edinburgh, Storbritannien, EH164SA
- Rekrytering
- Royal Infirmary of Edinburgh
-
Kontakt:
- Neeraj Dhaun, MBChB PhD
-
-
Deltagandekriterier
Urvalskriterier
Åldrar som är berättigade till studier
Tar emot friska volontärer
Kön som är behöriga för studier
Testmetod
Studera befolkning
As above
Beskrivning
Inclusion Criteria:
-
Patients will be eligible to take part in the study if they attend NHS Lothian inpatient or outpatient services and can be classified as being at increased risk of CVD. This will include, but is not limited to, the following subgroups:
- CKD as defined by the Kidney Disease Outcome Quality Initiative (K/DOQI) classification
- AKI as defined by the Kidney Disease Improving Global Outcomes (KDIGO) classification
- Small vessel vasculitis
- Kidney transplant recipient
- Kidney donor We will also recruit a healthy control group from the community.
Exclusion Criteria:
- Age <18 years and >90 years
- Lack of ability to provide informed consent
Studieplan
Hur är studien utformad?
Designdetaljer
- Observationsmodeller: COHORT
- Tidsperspektiv: PROSPECTIVE
Kohorter och interventioner
Grupp / Kohort |
Intervention / Behandling |
|---|---|
|
Health
Healthy individuals with no known medical condition and taking no regular medication |
Assessment of 24 hour blood pressure and arterial stiffness using Mobil-o-graph device |
|
Acute kidney injury
Individuals with acute kidney injury as defined by KDIGO criteria |
Assessment of 24 hour blood pressure and arterial stiffness using Mobil-o-graph device |
|
Chronic kidney disease
Individuals with chronic kidney disease as defined by KDIGO criteria |
Assessment of 24 hour blood pressure and arterial stiffness using Mobil-o-graph device |
|
Small vessel vasculitis
Individuals with active small vessel vasculitis an diagnosed by a specialist physician |
Assessment of 24 hour blood pressure and arterial stiffness using Mobil-o-graph device |
|
Kidney transplant recipient
Individuals who have received a kidney transplant |
Assessment of 24 hour blood pressure and arterial stiffness using Mobil-o-graph device |
|
Kidney donor
Individuals who have donated a kidney for transplantation |
Assessment of 24 hour blood pressure and arterial stiffness using Mobil-o-graph device |
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Nocturnal BP dip
Tidsram: 24 hours
|
Percentage change between mean day-time and mean night-time blood pressure |
24 hours
|
|
Nocturnal arterial stiffness dip
Tidsram: 24 hours
|
Percentage change between mean day-time and mean night-time arterial stiffness |
24 hours
|
Sekundära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Change in urine ET-1 concentration when measured in the morning (06:00 - 12:00) and in the evening (18:00-00:00)
Tidsram: Morning (06:00-12:00) and evening (18:00-00:00)
|
Measurement of urine ET-1 concentration in the morning (06:00 - 12:00) and in the evening (18:00-00:00) |
Morning (06:00-12:00) and evening (18:00-00:00)
|
|
Change in plasma ET-1 concentration when measured in the morning (06:00 - 12:00) and in the evening (18:00-00:00)
Tidsram: Morning (06:00-12:00) and evening (18:00-00:00)
|
Measurement of plasma ET-1 concentration in the morning (06:00 - 12:00) and in the evening (18:00-00:00) |
Morning (06:00-12:00) and evening (18:00-00:00)
|
Samarbetspartners och utredare
Sponsor
Utredare
- Huvudutredare: Neeraj Dhaun, MBChB PhD, University of Edinburgh
Studieavstämningsdatum
Studera stora datum
Studiestart (Faktisk)
Primärt slutförande (Beräknad)
Avslutad studie (Beräknad)
Studieregistreringsdatum
Först inskickad
Först inskickad som uppfyllde QC-kriterierna
Första postat (Faktisk)
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senast verifierad
Mer information
Termer relaterade till denna studie
Ytterligare relevanta MeSH-villkor
- Urogenitala sjukdomar
- Patologiska processer
- Manliga urogenitala sjukdomar
- Njursjukdomar
- Urologiska sjukdomar
- Kvinnliga urogenitala sjukdomar
- Kvinnliga urogenitala sjukdomar och graviditetskomplikationer
- Kronisk sjukdom
- Sjukdomsegenskaper
- Njurinsufficiens
- Patologiska tillstånd, tecken och symtom
- Njurinsufficiens, kronisk
- Diagnostiska tekniker och procedurer
- Diagnos
- Cirkulations- och andningsfysiologiska fenomen
- Läkarundersökning
- Vitala tecken
- Hemodynamik
- Kardiovaskulära fysiologiska fenomen
- Blodtryck
- Vaskulär styvhet
Andra studie-ID-nummer
- AC19178
Plan för individuella deltagardata (IPD)
Planerar du att dela individuella deltagardata (IPD)?
IPD-planbeskrivning
There is no plan to share IPD
Läkemedels- och apparatinformation, studiedokument
Studerar en amerikansk FDA-reglerad läkemedelsprodukt
Studerar en amerikansk FDA-reglerad produktprodukt
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .